Explore more publications!

Coca-Cola Reports 3 Percent Decline in Shares

(MENAFN) Coca-Cola stock tumbled approximately 3% in pre-market trading Tuesday after the beverage giant disclosed fourth-quarter sales figures that missed analyst forecasts.

The Atlanta-based company posted revenue of $11.82 billion for the October-December period of 2025, undershooting Wall Street expectations, according to financial results unveiled Tuesday.

Net income attributable to shareholders reached $2.27 billion, or $0.53 per share, for the final quarter—an increase from $2.2 billion, or $0.51 per share, in the corresponding period of the prior year.

However, operating income contracted 32% during the quarter, though it expanded 38% on a full-year basis, the company disclosed in a statement.

Looking ahead to 2026, Coca-Cola forecasts organic revenue expansion of 4% to 5% and comparable earnings per share growth in the 7% to 8% range for the complete fiscal year.

"Juice, value-added dairy and plant-based beverages declined 3% for both the quarter and the full year, as growth in Latin America was more than offset by declines in Asia Pacific and Europe, Middle East & Africa (EMEA)," the firm said.

MENAFN11022026000045017169ID1110725150


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions